Preclinical development of Meta-[At-211]astatobenzylguanidine ([At-211]MABG) as an alpha particle emitting systemic targeted radiotherapeutic for neuroblastoma (NB).

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Batra, V; Makvandi, M; Ranieri, P; Tsang, M; Hou, C; Li, Y; Vaidyanathan, G; Maris, J; Pryma, D

Published Date

  • May 1, 2015

Published In

Volume / Issue

  • 56 / 3

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1535-5667

International Standard Serial Number (ISSN)

  • 0161-5505

Conference Name

  • Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging

Conference Location

  • Baltimore, MD

Conference Start Date

  • June 6, 2015

Conference End Date

  • June 10, 2015